OHSU leadership on stage at AACR
Dozens of OHSU Knight Cancer Institute researchers commanded the spotlight at the American Association for Cancer Research Annual Meeting in Orlando, Florida. Lisa Coussens, Ph.D., who concluded...
Ten imaginative ideas for fighting cancer funded by the Kuni Foundation
Bring cancer screening to underserved places with simplified tests that don’t require a doctor. Disrupt the niche of cancer stem cells so they can’t regenerate tumors. Defeat brain tumors by...
A surgeon-scientist blazes a new path to immune-based cancer treatment
It’s a paradox: The immune system’s cancer-fighting T cells target and infiltrate tumors, but often they stop working and let the cancer grow. Trained as a surgeon, Robert Eil, M.D., had...
MRI innovation reveals cells’ energy activity in organs and tissues
To survive, every cell in the body puts enormous energy into sustaining the right balance of water and essential electrolytes. Researchers at Oregon Health & Science University have developed a...
Chemistry researchers identify promising next-generation cancer treatment
Drugs known as PARP-1 inhibitors have emerged as an important but limited treatment option for certain cancers. Now scientists at Oregon Health & Science University have uncovered a new class of...
The cancer kept coming back
His life was blasted apart by a rare but vicious type of cancer. Could an experimental treatment help? When Derek Fadness woke up, the room was dark and his face was swaddled in bandages. He could...
Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
A better roadmap for beating a deadly leukemia
Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults — and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a...
New approach finds drug combinations to stop cancer
In the future, the most effective cancer drug therapies will likely be combinations that not only target cancer cells but also drive cancer-suppressing responses in non-cancer cells in and around...
New treatment strategy aims to stop rare liver cancer
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
Treatment advance for an incurable blood cancer
Researchers are reporting an impressive advance in the treatment of mantle cell lymphoma, a type of blood cancer that is considered incurable. Patients who took the drug ibrutinib in addition to a...